Rang	Name	Position
1	Mr. Matthew Gline	CEO & Director
2	Dr. Eric Venker M.D., Pharm.D.	President & CEO of Immunovant
3	Dr. Mayukh Sukhatme M.D.	President, Chief Investment Officer & Director
4	Dr. Frank M. Torti M.B.A., M.D.	President & Vant Chair
5	Mr. Richard Pulik	Chief Financial Officer
6	Ms. Jennifer Humes	Chief Accounting Officer
7	Mr. Ian Rosenblum	Chief Information Officer
8	Mr. Sam Kaplan	General Counsel
9	Ms. Kelly Graff	Head of People
10	Mr. Alex Gasner	Executive Vice President of Roivant Health

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	FMR Inc	11,22%	2,87 Mrd. USD
2	BlackRock Inc	6,68%	1,71 Mrd. USD
3	Morgan Stanley - Brokerage Accounts	5,90%	1,51 Mrd. USD
4	Qvt Financial LP	3,28%	0,84 Mrd. USD
5	Vanguard Capital Management, LLC	3,06%	0,78 Mrd. USD
6	Vanguard Portfolio Management, LLC	3,00%	0,77 Mrd. USD
7	The Goldman Sachs Group Inc	2,57%	0,66 Mrd. USD
8	State Street Corp	2,46%	0,63 Mrd. USD
9	UBS Group AG	2,42%	0,62 Mrd. USD
10	Assenagon Asset Management SA	2,32%	0,59 Mrd. USD
11	Farallon Capital Management, L.L.C.	1,98%	0,51 Mrd. USD
12	Geode Capital Management, LLC	1,62%	0,41 Mrd. USD
13	Adage Capital Partners Gp LLC	1,43%	0,37 Mrd. USD
14	Two Seas Capital LP	1,29%	0,33 Mrd. USD
15	Perceptive Advisors LLC	1,12%	0,29 Mrd. USD
16	Patient Square Capital LP	1,11%	0,28 Mrd. USD
17	Amvescap Plc.	1,04%	0,27 Mrd. USD
18	Darwin Global Management, Ltd.	0,93%	0,24 Mrd. USD
19	AQR Capital Management LLC	0,92%	0,24 Mrd. USD
20	Viking Global Investors LP	0,87%	0,22 Mrd. USD